| amdSYM, a new dominant recyclable marker cassette for Saccharomyces cerevisiae D Solis-Escalante, NGA Kuijpers, B Nadine, I Bolat, L Bosman, JT Pronk, ... FEMS yeast research 13 (1), 126-139, 2013 | 183 | 2013 |
| Are synthetic biology standards applicable in everyday research practice? H Tas, A Amara, ME Cueva, N Bongaerts, A Calvo‐Villamañán, ... Microbial Biotechnology 13 (5), 1304-1308, 2020 | 14 | 2020 |
| Low-cost anti-mycobacterial drug discovery using engineered E. coli N Bongaerts, Z Edoo, AA Abukar, X Song, S Sosa-Carrillo, ... Nature Communications 13 (1), 3905, 2022 | 10 | 2022 |
| A toolkit to enable hydrocarbon conversion in aqueous environments EK Brinkman, K Schipper, N Bongaerts, MJ Voges, A Abate, SA Wahl Journal of Visualized Experiments: JoVE, 2012 | 1 | 2012 |
| Low-cost drug discovery with engineered E. coli reveals an anti-mycobacterial activity of benazepril N Bongaerts, Z Edoo, AA Abukar, X Song, S Sosa Carrillo, AB Lindner, ... bioRxiv, 2021.03. 26.437171, 2021 | | 2021 |
| Morgen wordt alles beter. De mogelijkheden en ethiek van gentechnologie. M Verkerk, H Jochemsen, M Bikker, N Bongaerts, M Cornel, D van Dijk, ... | | 2020 |
| Target essential surrogate E. coli (TESEC): a technology platform for tuberculosis drug discovery and the investigation into the mutational landscape of drug targets N Bongaerts Université Paris Cité, 2019 | | 2019 |
| Cibles de substitution essentielles de E. coli comme outil de découverte d'antibiotiques et de mutations de résistance N Bongaerts | | 2019 |
| Nature: Collaborations in Design: Cooper Hewitt Design Triennial M McQuaid, K Van Mensvoort, AD Gorman, Michael John, Ginsberg, ... | | 2019 |
